Using Large Institutional or National Databases to Evaluate Prostate Cancer Outcomes and Patterns of Care: Possibilities and Limitations

por Su, Daniel, Jang, Thomas L.
Publicado 2011

Multimodal treatments for advanced prostate cancer

por Faiena, Izak, Kim, Isaac Y., Jang, Thomas L.
Publicado 2019

Editorial by Bendu K. Konneh, John T. Lafin and Aditya Bagrodia on pp. 341–342 of this issue: MicroRNA-371a-3p as a blood-based biomarker in testis cancer

por Ahmadi, Hamed, Jang, Thomas L., Daneshmand, Siamak, Ghodoussipour, Saum
Publicado 2021

Does Time to Adjuvant Chemotherapy after Radical Cystectomy Affect Survival in Muscle Invasive Bladder Cancer? A Systematic Review

por Kronstedt, Shane, Doppalapudi, Sai Krishnaraya, Boyle, Joseph, Chua, Kevin, Jang, Thomas L., Cacciamani, Giovanni E., Ghodoussipour, Saum
Publicado 2022

Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study

por Roberts, Calpurnyia B., Jang, Thomas L., Shao, Yu-Hsuan, Kabadi, Shaum, Moore, Dirk F., Lu-Yao, Grace L.
Publicado 2011

Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach

por Shinder, Brian M., Rhee, Kevin, Farrell, Douglas, Farber, Nicholas J., Stein, Mark N., Jang, Thomas L., Singer, Eric A.
Publicado 2017

Urologic oncology surgery during COVID-19: a rapid review of current triage guidance documents

por Shinder, Brian M., Patel, Hiren V., Sterling, Joshua, Tabakin, Alexandra L., Kim, Isaac Y., Jang, Thomas L., Singer, Eric A.
Publicado 2020

Performing all major surgical procedures robotically will prolong wait times for surgery

por Shinder, Brian M, Farber, Nicholas J, Weiss, Robert E, Jang, Thomas L, Kim, Isaac Y, Singer, Eric A, Elsamra, Sammy E
Publicado 2017

Adapting Urology Residency Training in the COVID-19 Era

por Kwon, Young Suk, Tabakin, Alexandra L., Patel, Hiren V., Backstrand, Jeffrey R., Jang, Thomas L., Kim, Isaac Y., Singer, Eric A.
Publicado 2020

Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations

por Kim, Isaac E., Kim, Daniel D., Kim, Sinae, Ma, Shuangge, Jang, Thomas L., Singer, Eric A., Ghodoussipour, Saum, Kim, Isaac Yi
Publicado 2022

Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, surv...

por Kwon, Young Suk, Wang, Wei, Srivastava, Arnav, Jang, Thomas L., Singer, Eric A., Parikh, Rahul R., Kim, Wun-Jae, Kim, Isaac Yi
Publicado 2021

Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer

por Farber, Nicholas J., Faiena, Izak, Dombrovskiy, Viktor, Tabakin, Alexandra L., Shinder, Brian, Patel, Rutveej, Elsamra, Sammy E., Jang, Thomas L., Singer, Eric A., Weiss, Robert E.
Publicado 2018

Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers

por Faiena, Izak, Kim, Sinae, Farber, Nicholas, Kwon, Young Suk, Shinder, Brian, Patel, Neal, Salmasi, Amirali H., Jang, Thomas, Singer, Eric A., Kim, Wun-Jae, Kim, Isaac Y.
Publicado 2017

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era

por Kim, Isaac E., Jang, Thomas L., Kim, Sinae, Lee, David Y., Kim, Daniel D., Singer, Eric A., Ghodoussipour, Saum, Stein, Mark N., Aron, Monish, Dall’Era, Marc A., Yi Kim, Isaac
Publicado 2021

Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond

por Srivastava, Arnav, Patel, Hiren V., Kim, Sinae, Shinder, Brian, Sterling, Joshua, Tabakin, Alexandra L., Polotti, Charles F., Saraiya, Biren, Mayer, Tina, Kim, Isaac Y., Ghodoussipour, Saum, Patel, Hiten D., Jang, Thomas L., Singer, Eric A.
Publicado 2021

Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer

por Tan, Xiang‐Lin, E, Jian‐Yu, Lin, Yong, Rebbeck, Timothy R., Lu, Shou‐En, Shang, Mingyi, Kelly, William K., D'Amico, Anthony, Stein, Mark N., Zhang, Lanjing, Jang, Thomas L., Kim, Isaac Yi, Demissie, Kitaw, Ferrari, Anna, Lu‐Yao, Grace
Publicado 2020

Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy

por Kim, Isaac Yi, Mitrofanova, Antonina, Panja, Sukanya, Sterling, Joshua, Srivastava, Arnav, Kim, Juliana, Kim, Sinae, Singer, Eric A., Jang, Thomas L., Ghodoussipour, Saum, Saraiya, Biren, Mayer, Tina, Sabaawy, Hatem E., Yuh, Bertram, Byun, Seok Soo, Kim, Wun-Jae, Horie, Shigeo
Publicado 2022

TGF-β Regulates DNA Methyltransferase Expression in Prostate Cancer, Correlates with Aggressive Capabilities, and Predicts Disease Recurrence

por Zhang, Qiang, Chen, Lin, Helfand, Brian T., Jang, Thomas L., Sharma, Vidit, Kozlowski, James, Kuzel, Timothy Michael, Zhu, Lihua J., Yang, Ximing J., Javonovic, Borko, Guo, Yinglu, Lonning, Scott, Harper, Jay, Teicher, Beverly A., Brendler, Charles, Yu, Nengwang, Catalona, William J., Lee, Chung
Publicado 2011

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer

por Yuh, Bertram E., Kwon, Young Suk, Shinder, Brian M., Singer, Eric A., Jang, Thomas L., Kim, Sinae, Stein, Mark N., Mayer, Tina, Ferrari, Anna, Lee, Nara, Parikh, Rahul R., Ruel, Nora, Kim, Wun-Jae, Horie, Shigeo, Byun, Seok-Soo, Ahlering, Thomas E., Kim, Isaac Yi
Publicado 2019